Physician profile
Daisy B Dillon
NPI 1861826406
$1,019.60
in general payments reported to CMS, 2019-2025
18 companies · $423 in 2025
The $423 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $189 · 2022: $62.62 · 2023: $70.38 · 2024: $274 · 2025: $423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $768.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $767.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $141.59 | 2021-2022 | |
| Kestra Medical Technology Services, INC. | $134.92 | 2023-2025 | Assure Wcd |
| Alnylam Pharmaceuticals INC. | $103.47 | 2024-2025 | Onpattro |
| Amgen INC. | $101.04 | 2023-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $97.46 | 2021 | |
| Cvrx, INC. | $86.89 | 2024-2025 | Barostim Neo System |
| Atricure, INC. | $57.12 | 2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System, Synergy Ablation System |
| Astrazeneca Pharmaceuticals Lp | $47.18 | 2022-2024 | Farxiga |
| Pfizer INC. | $41.82 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $34.56 | 2024-2025 | Camzyos |
| Abbott Laboratories | $27.82 | 2025 | Mitraclip |
| Kiniksa Pharmaceuticals International, Plc | $23.75 | 2024 | Arcalyst |
| Scpharmaceuticals INC. | $23.73 | 2025 | |
| Novo Nordisk INC | $23.34 | 2024 | Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $21.07 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.19 | 2025 | |
| Novartis Pharmaceuticals Corporation | $18.66 | 2024 | |
| Sanofi-Aventis U.S. LLC | $15.99 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daisy Dillon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.